IP Library › Granted Patent US 5,968,813
Granted Patent Utility
US 5,968,813 · App. 09/084,596

Use of xyloglucan endotransglycosylase (XET)

Inventors: Lene Venke Kofod, Henrik Lund
Patented Case View Patent ↗
Granted: Oct 19, 1999 Filed: May 26, 1998
Inventors
Lene Venke Kofod
Henrik Lund
Assignee (at issue)
Novo Nordisk A/S

This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.

Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 5,968,813
App. No.
09/084,596
Filed
1998-05-26
Granted
1999-10-19
Kind
A